Physician profile
Patrick T Karl
NPI 1073795142
$2,412.94
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $661 · 2021: $784 · 2022: $267.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $497.78 | 2019-2021 | |
| Boston Scientific Corporation | $361.59 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $329.43 | 2019-2022 | |
| Nevro Corp. | $310.33 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $218.98 | 2019-2022 | |
| Forte Bio-Pharma LLC | $99.58 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $87.54 | 2019-2022 | |
| Redhill Biopharma INC. | $81.99 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $75.22 | 2020-2021 | |
| Pfizer INC. | $72.26 | 2019-2021 | |
| Virtus Pharmaceuticals LLC | $50.60 | 2021 | |
| Amgen INC. | $39.51 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $31.26 | 2021 | |
| Abbvie INC. | $25.55 | 2021 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $19.03 | 2019 | |
| Almatica Pharma LLC | $14.91 | 2021 | |
| Grt US Holding, INC. | $14.59 | 2022 | |
| Scilex Pharmaceuticals INC. | $14.09 | 2022 | |
| Medtronic USA, INC. | $13.28 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.55 | 2019 | |
| Allergan, INC. | $11.11 | 2020 | |
| Daiichi Sankyo INC. | $10.76 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Karl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.